Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal HypertensionChangpeng Zhu, Wei‐Fen Xie, Jordi Gracia‐Sancho et al.|Gastroenterology|2024Cited by 12